Lucy Wambui first suspected she was HIV-positive in 2000, when her baby fell ill and died. At the time, treatment for the ...
Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...
Key funding to help lessen the spread of HIV in Austin could be affected as part of the federal Department of Government ...
News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Dr. Lisa Abuogi, an associate professor in the Department of Pediatrics at the University of Colorado and the medical ...
A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...
Carl Schmid, the executive director of the HIV+Hepatitis Policy Institute in Washington, told Reuters he had been told by a ...
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Many HIV prevention and treatment programs focus on LGBTQ people ... Millions of lives are affected and rationing of medication and care has started in Africa. When might we need to start to ...
Shares of Theratechnologies jumped after the company received Food and Drug Administration approval for Egrifta WR, its treatment for excess abdominal fat in adults with HIV and lipodystrophy.
The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results